股本结构
单位：万股
| 公告日期 | 2024-04-26 | 2024-04-08 | 2024-04-08 | 2023-11-30 | 2023-11-13 | 2023-11-13 |
|---|---|---|---|---|---|---|
| 证券总股本 | 278.44 | 278.44 | 204.63 | 204.64 | 204.63 | 184.23 |
| 普通股本 | 278.44 | 278.44 | 204.63 | 204.64 | 204.63 | 184.23 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-24 | 2024-04-08 | 2023-12-31 | 2023-11-27 | 2023-11-13 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-26 | 278.44 | 未披露 | 定期报告 | 2024-04-24 |
| 2024-04-08 | 278.44 | 未披露 | 定期报告 | 2024-04-08 |
| 2024-04-08 | 204.63 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock, net of offering costs of $785,084
Exercise of pre-funded warrants
Exercise of options
Rounding-up of fractional shares due to reverse stock split
|
2023-12-31 |
| 2023-11-30 | 204.64 | 未披露 | 定期报告 | 2023-11-27 |
| 2023-11-13 | 204.63 | 未披露 | 定期报告 | 2023-11-13 |
| 2023-11-13 | 184.23 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock
|
2023-09-30 |
| 2023-08-11 | 166.23 | 未披露 | 定期报告 | 2023-08-11 |
| 2023-08-01 | 166.23 | 未披露 | 定期报告 | 2023-07-07 |
| 2023-08-11 | 166.23 | 未披露 | 定期报告 | 2023-06-30 |
| 2023-05-15 | 166.23 | 未披露 | 定期报告 | 2023-05-15 |
| 2023-05-01 | 166.24 | 未披露 | 定期报告 | 2023-05-01 |
| 2023-04-17 | 166.24 | 未披露 | 定期报告 | 2023-04-17 |
| 2023-05-15 | 166.23 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Exercise of options
Rounding-up of fractional shares due to reverse stock split
|
2023-03-31 |
| 2023-02-08 | 164.47 | 未披露 |
更多>>
NanoVibronix, Inc. announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares.
|
2023-02-09 |
| 2023-02-08 | 3289.44 | 未披露 | 定期报告 | 2023-02-08 |
| 2022-11-30 | 3279.38 | 未披露 |
更多>>
Common Stock offered 4,800,000 shares by the company
|
2022-12-01 |
| 2022-11-30 | 2799.38 | 未披露 | 定期报告 | 2022-11-28 |
| 2022-11-14 | 2799.78 | 未披露 | 定期报告 | 2022-09-30 |
| 2022-04-15 | 2799.78 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Exercise of warrants
Conversion of Series C Preferred Stock into Common Stock
Conversion of Series D Preferred Stock into Common Stock
Conversion of Series E Preferred Stock into Common Stock
|
2021-12-31 |
| 2021-11-15 | 2794.68 | 未披露 | 定期报告 | 2021-11-15 |
| 2021-11-16 | 2784.48 | 0.02 | 定期报告 | 2021-11-05 |
| 2021-11-15 | 2717.81 | 66.68 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of warrants
Conversion of preferred stock to common stock
|
2021-09-30 |
| 2021-08-16 | 2410.96 | 154.18 | 定期报告 | 2021-06-30 |
| 2021-05-24 | 2410.96 | 154.18 |
更多>>
From December 31, 2020 To March 31, 2021
Exercise of warrants
|
2021-03-31 |
| 2021-03-03 | 2410.96 | 154.18 | 定期报告 | 2021-02-23 |
| 2021-04-15 | 2124.65 | 154.18 |
更多>>
from December 31, 2019 to December 31, 2020
Exchange of Series C Preferred Stock into Common Stock
Exchange of Series D Preferred Stock into Common Stock
Exchange of Series E Preferred Stock into Common Stock
Issuance of common stock for services
Issuance of common stock for cash
Common stock issued as liability due to lack of authorized shares
|
2020-12-31 |
| 2020-11-16 | 1339.37 | 未披露 | 定期报告 | 2020-11-15 |
| 2020-11-16 | 1249.37 | 337.74 |
更多>>
From June 30, 2020 to September 30, 2020
Exchange of Series C Preferred Stock into Common Stock
Exchange of Series D Preferred Stock into Common Stock
Exchange of Series E Preferred Stock into Common Stock
Issuance of common stock for services
Issuance of common stock for cash, net
|
2020-09-30 |
| 2020-09-25 | 1236.29 | 未披露 |
更多>>
1.Common Stock offered by the company 1,794,783 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 10,568,088 shares outstanding as of September 22, 2020.
|
2020-09-25 |
| 2020-09-22 | 1056.81 | 未披露 | 定期报告 | 2020-09-22 |
| 2020-08-27 | 932.21 | 未披露 |
更多>>
1.Common Stock offered by the company 4,333,334 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 4,988,764 shares outstanding as of August 21, 2020.
|
2020-08-27 |
| 2020-08-19 | 498.88 | 未披露 | 定期报告 | 2020-08-18 |
| 2020-07-21 | 461.38 | 440.84 | 定期报告 | 2020-07-17 |
| 2020-08-19 | 431.38 | 470.84 | 定期报告 | 2020-06-30 |
| 2020-06-15 | 431.38 | 501.19 | 定期报告 | 2020-06-12 |
| 2020-07-06 | 431.38 | 470.84 |
更多>>
From December 31, 2019 to March 31, 2020
Exchange of Series E Preferred Stock into Common Stock
|
2020-03-31 |
| 2020-05-20 | 420.38 | 481.84 |
更多>>
from December 31, 2018 to December 31, 2019
Exchange of common stock into Preferred Stock
Issuance of Series E Preferred Stock
Issuance of common stock as compensation for services
Sale of common stock
Exercise of options
|
2019-12-31 |
| 2019-11-19 | 445.38 | 未披露 | 定期报告 | 2019-11-15 |
| 2019-11-19 | 443.00 | 454.34 |
更多>>
from June 30, 2019 to September 30, 2019
Sale of common stock
|
2019-09-30 |
| 2019-10-01 | 443.00 | 454.36 | 定期报告 | 2019-09-25 |
| 2019-08-14 | 443.00 | 未披露 | 定期报告 | 2019-08-13 |
| 2019-08-14 | 414.00 | 433.34 |
更多>>
from March 31, 2019 to June 30, 2019
Issuance of preferred series E stock
Exercise of stock options
|
2019-06-30 |
| 2019-05-20 | 411.49 | 未披露 | 定期报告 | 2019-05-17 |
| 2019-05-13 | 410.11 | 273.34 | 定期报告 | 2019-05-10 |
| 2019-05-02 | 409.00 | 273.34 | 定期报告 | 2019-05-01 |
| 2019-04-30 | 408.20 | 273.31 | 定期报告 | 2019-04-18 |
| 2019-05-20 | 407.66 | 273.34 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of common stock as compensation for services
|
2019-03-31 |
| 2019-04-15 | 380.15 | 273.34 |
更多>>
from December 31, 2017 to December 31, 2018
Exchange of Common Stock into Preferred D
Exercise of warrants for Common stock
Exercise of stock options for Common stock
|
2018-12-31 |
| 2018-12-31 | 378.15 | 273.35 | 定期报告 | 2018-12-28 |
| 2018-11-14 | 400.35 | 未披露 | 定期报告 | 2018-11-14 |
| 2018-11-14 | 396.71 | 248.34 |
更多>>
From January 1, 2018 to September 30, 2018
Exercise of Warrants
|
2018-09-30 |
| 2018-08-14 | 395.80 | 248.34 |
更多>>
From January 1, 2018 to June 30, 2018
Exercise of Warrants
|
2018-06-30 |
| 2018-03-29 | 393.59 | 248.34 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of Common and Preferred C stock upon cashless exercise of warrants and reclassification from liability to equity
Proceeds from issuance of Common stock, Preferred D stock and warrants, net of issuance costs
Conversion of convertible notes and accrued interest into Common and Preferred D stock
Conversion of Preferred D into Common stock
|
2017-12-31 |
| 2017-11-14 | 377.48 | 未披露 | 定期报告 | 2017-11-14 |
| 2017-11-06 | 385.72 | 未披露 |
更多>>
1.Common stock offered by us in this offering 1,224,488 shares of our common stock, par value $0.001 per share.
The number of shares to be outstanding immediately before and immediately after this offering is based on 2,632,710 shares of our common stock and 1,951,261 shares of Series C Preferred Stock outstanding as of June 30, 2017
|
2017-11-02 |
| 2017-10-31 | 263.27 | 195.13 | 定期报告 | 2017-06-30 |
From December 31, 2022 to December 31, 2023
Issuance of common stock, net of offering costs of $785,084
Exercise of pre-funded warrants
Exercise of options
Rounding-up of fractional shares due to reverse stock split
From June 30, 2023 to September 30, 2023
Issuance of common stock
From December 31, 2022 to March 31, 2023
Exercise of options
Rounding-up of fractional shares due to reverse stock split
NanoVibronix, Inc. announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares.
Common Stock offered 4,800,000 shares by the company
From December 31, 2020 to December 31, 2021
Exercise of warrants
Conversion of Series C Preferred Stock into Common Stock
Conversion of Series D Preferred Stock into Common Stock
Conversion of Series E Preferred Stock into Common Stock
From June 30, 2021 to September 30, 2021
Exercise of warrants
Conversion of preferred stock to common stock
From December 31, 2020 To March 31, 2021
Exercise of warrants
from December 31, 2019 to December 31, 2020
Exchange of Series C Preferred Stock into Common Stock
Exchange of Series D Preferred Stock into Common Stock
Exchange of Series E Preferred Stock into Common Stock
Issuance of common stock for services
Issuance of common stock for cash
Common stock issued as liability due to lack of authorized shares
From June 30, 2020 to September 30, 2020
Exchange of Series C Preferred Stock into Common Stock
Exchange of Series D Preferred Stock into Common Stock
Exchange of Series E Preferred Stock into Common Stock
Issuance of common stock for services
Issuance of common stock for cash, net
1.Common Stock offered by the company 1,794,783 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 10,568,088 shares outstanding as of September 22, 2020.
1.Common Stock offered by the company 4,333,334 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 4,988,764 shares outstanding as of August 21, 2020.
From December 31, 2019 to March 31, 2020
Exchange of Series E Preferred Stock into Common Stock
from December 31, 2018 to December 31, 2019
Exchange of common stock into Preferred Stock
Issuance of Series E Preferred Stock
Issuance of common stock as compensation for services
Sale of common stock
Exercise of options
from June 30, 2019 to September 30, 2019
Sale of common stock
from March 31, 2019 to June 30, 2019
Issuance of preferred series E stock
Exercise of stock options
from December 31, 2018 to March 31, 2019
Issuance of common stock as compensation for services
from December 31, 2017 to December 31, 2018
Exchange of Common Stock into Preferred D
Exercise of warrants for Common stock
Exercise of stock options for Common stock
From January 1, 2018 to September 30, 2018
Exercise of Warrants
From January 1, 2018 to June 30, 2018
Exercise of Warrants
from December 31, 2016 to December 31, 2017
Issuance of Common and Preferred C stock upon cashless exercise of warrants and reclassification from liability to equity
Proceeds from issuance of Common stock, Preferred D stock and warrants, net of issuance costs
Conversion of convertible notes and accrued interest into Common and Preferred D stock
Conversion of Preferred D into Common stock
1.Common stock offered by us in this offering 1,224,488 shares of our common stock, par value $0.001 per share.
The number of shares to be outstanding immediately before and immediately after this offering is based on 2,632,710 shares of our common stock and 1,951,261 shares of Series C Preferred Stock outstanding as of June 30, 2017